Dysregulation of β-chemokines in the lungs of HIV-1-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 4, 2001, Pages 305-314

  Aung, Htin ^b   McKenna, Siobhan M ^c   Ketoff, Nabila R ^c   Jones, Leola ^c   Wu, Mianda ^c   Hejal, Rana ^c   Rich, Elizabeth A ^c   Toossi, Zahra ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

CCR5; MCP 1; MIP 1 ; MIP 1 ; RANTES

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ARTICLE; CLINICAL ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; VIRUS REPLICATION;

EID: 0035306911     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200104010-00002     Document Type: Article

References (33)

1. Autran B, Mayaud CM, Raphael M, et al. Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 1988;2:179-83.
2. Guillon JM, Autran B, Denis M, et al. Human immunodeficiency virus-related lymphocytic alveolitis. Chest 1988;94:1264-70.
3. Levy JA. HIV and the pathogenesis of AIDS. American Society for Microbiology Press; 1994;35.
4. Garzino-Demo A, DeVico AL, Cocchi F, Gallo RC. Beta-chemokines and protection from HIV type 1 disease. AIDS Res Hum Retroviruses 1998;14(Suppl 2):S177-84.
5. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
6. Mandl CW, Aberle SW, Henkel JH, et al. Possible influence of the mutant CCR5 Allele on vertical transmission of HIV-1. J Med Virol 1998;55:51-5.
7. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: more than an attraction. Immunity 1998;9:1-11.
8. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997;349:490-5.
9. Trkola A, Dragic T, Arthos J, et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996;384:184-7.
10. Worgall S, Connor R, Kaner RJ, et al. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages. J Virol 1999;73:5865-74.
11. Stoler MH, Eskin TA, Benn S, et al. Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA 1986;256:2360-4.
12. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-93.
13. Rich EA, Chen IS, Zack JA, et al. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 1992;89:176-83.
14. Agostini C, Zambello R, Trentin L, et al. Prognostic significance of the evaluation of bronchoalveolar lavage cell populations in patients with HIV-1 infection and pulmonary involvement. Chest 1991;100:1601-6.
15. Hirsch CS, Ellner JJ, Russell DG, et al. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994;152:743-53.
16. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968;97:77-89.
17. Weiner MS, Bianco C, Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood 1973;42:939-46.
18. Rich EA, Tweardy DJ, Fujiwara H, et al. Spectrum of immuno-regulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis 1987;136:258-65.
19. Johnson WD, Mei B, Cohn ZA. The Separation, long term cultivation and maturation of the human monocyte. J Exp Med 1977; 146:1613-26.
20. 8+ T cells. Science 1995-270: 1811-5.
21. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996; 2:412-7.
22. Coffey MJ, Woffendin C, Phare SM, et al. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am J Physiol 1997;272:L1025-9.
23. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
24. Bisset LR, Rothen M, Joller-Jemelka HI, et al. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 1 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 1997;11:485-91.
25. Weiss JM, Nath A, Major EO, et al. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 1999;163: 2953-9.
26. Cinque P, Vago L, Mengozzi M, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998;12:1327-32.
27. Kelder W, McArthur JC, Nance-Sproson T, et al. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998;44:831-5.
28. Lin Y, Gong J, Zhang M, et al. Production of monocyte chemo-attractant protein 1 in tuberculosis patients. Infect Immun 1998;66: 2319-22.
29. Kurihara T, Warr G, Loy J, et al. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997;186:1757-62.
30. Kakkanaiah VN, Ojo-Amaize EA, Peter JB. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals. Clin Diagn Lab Immunol 1998;5:499-502.
31. Xiao L, Rudolph DL, Owen SM, Spira TJ, Lal RB. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 1998;12: F137-43.
32. McKenzie SW, Dallalio G, North M, et al. Serum chemokine levels in patients with non-progressing HIV infection. AIDS 1996; 10:F29-33.
33. Zanussi S, D'Andrea M, Simonelli C, et al. Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients. AIDS 1996;10:1431-2.